Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

FDA-Approved Phase I Clinical Trial of Autologous Neural Progenitors Injected Intrathecally in Multiple Sclerosis
Multiple Sclerosis
(-)
172
Authors/Disclosures
Violaine K. Harris, PhD (Tisch Multiple Sclerosis Research Center of NY)
PRESENTER 		No disclosure on file
No disclosure on file
Sydney Chirls No disclosure on file
Saud Sadiq, BS, FÂ鶹´«Ã½Ó³»­ (Tisch Multiple Sclerosis Research Center of New York) Ms. Brewi has nothing to disclose.
Dara G. Jamieson, MD Dr. Jamieson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Jamieson has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Medico-legal. Dr. Jamieson has received publishing royalties from a publication relating to health care. Dr. Jamieson has received personal compensation in the range of $100,000-$499,999 for serving as a Expert, Consultant with Health and Human Services, Department of Justice.